Following the
The person responsible for the release of this announcement on behalf of
Contact:
Tel: +44 7776 477050
Email: uk-investors@hikma.uk.com
About
(C) 2021 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,837 GBX | +0.05% | +1.05% | +2.68% |
Jun. 24 | Teva launches generic version of Novo Nordisk's diabetes drug Victoza | RE |
Jun. 20 | Fitch Confirms Ratings, Outlook on Hikma Pharmaceuticals on 'Defensive Market Position' | MT |
Following the
The person responsible for the release of this announcement on behalf of
Contact:
Tel: +44 7776 477050
Email: uk-investors@hikma.uk.com
About
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+2.68% | 5.29B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |